Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Annals of the Rheumatic Diseases
|
May 3, 2014
Is there a need for new agents with novel mechanisms of action in psoriatic arthritis?
Carl Orr, Douglas James Veale
International Journal of Molecular Sciences
|
April 13, 2023
Targeted Therapies in Psoriatic Arthritis-An Update
Sonia Sundanum, Carl Orr, Douglas Veale
Seminars in Immunopathology
|
May 17, 2017
Cellular and molecular perspectives in rheumatoid arthritis
Douglas J Veale, Carl Orr, Ursula Fearon
Clinical Medicine (London, England)
|
June 3, 2017
Lesson of the month 1: Septic arthritis with normal acute phase reactants and white cell count in a patient receiving tocilizumab
Richard Conway, Carl Orr, Geraldine M McCarthy
The Lancet. Rheumatology
|
January 27, 2024
Targeting GM-CSF in rheumatological conditions: risk of PAP
Leah Rooney, Douglas J Veale, Carl Orr, et al.
Arthritis Research & Therapy
|
June 10, 2015
Toll-like receptor 2 (TLR2) induces migration and invasive mechanisms in rheumatoid arthritis
Trudy McGarry, Douglas J Veale, Wei Gao, et al.
Arthritis Research & Therapy
|
July 10, 2025
Investigation of serum biomarkers in rheumatoid and psoriatic arthritis patients for disease-specific signatures
James D Veale, Áine Gorman, Douglas J Veale, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
September 8, 2017
Reply
Cormac McCarthy, Emer P Reeves, Carl Orr, et al.
The Journal of Rheumatology
|
October 17, 2016
Success Rate and Utility of Ultrasound-guided Synovial Biopsies in Clinical Practice
Aurélie Najm, Carl Orr, Marie-Françoise Heymann, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
July 22, 2017
Synovial Immunophenotype and Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis Patients: Relationship to Treatment Response and Radiologic Prognosis
Carl Orr, Aurelie Najm, Monika Biniecka, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Annals of the Rheumatic Diseases
|
May 3, 2014
Is there a need for new agents with novel mechanisms of action in psoriatic arthritis?
Carl Orr, Douglas James Veale
International Journal of Molecular Sciences
|
April 13, 2023
Targeted Therapies in Psoriatic Arthritis-An Update
Sonia Sundanum, Carl Orr, Douglas Veale
Seminars in Immunopathology
|
May 17, 2017
Cellular and molecular perspectives in rheumatoid arthritis
Douglas J Veale, Carl Orr, Ursula Fearon
Clinical Medicine (London, England)
|
June 3, 2017
Lesson of the month 1: Septic arthritis with normal acute phase reactants and white cell count in a patient receiving tocilizumab
Richard Conway, Carl Orr, Geraldine M McCarthy
The Lancet. Rheumatology
|
January 27, 2024
Targeting GM-CSF in rheumatological conditions: risk of PAP
Leah Rooney, Douglas J Veale, Carl Orr, et al.
Arthritis Research & Therapy
|
June 10, 2015
Toll-like receptor 2 (TLR2) induces migration and invasive mechanisms in rheumatoid arthritis
Trudy McGarry, Douglas J Veale, Wei Gao, et al.
Arthritis Research & Therapy
|
July 10, 2025
Investigation of serum biomarkers in rheumatoid and psoriatic arthritis patients for disease-specific signatures
James D Veale, Áine Gorman, Douglas J Veale, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
September 8, 2017
Reply
Cormac McCarthy, Emer P Reeves, Carl Orr, et al.
The Journal of Rheumatology
|
October 17, 2016
Success Rate and Utility of Ultrasound-guided Synovial Biopsies in Clinical Practice
Aurélie Najm, Carl Orr, Marie-Françoise Heymann, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
July 22, 2017
Synovial Immunophenotype and Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis Patients: Relationship to Treatment Response and Radiologic Prognosis
Carl Orr, Aurelie Najm, Monika Biniecka, et al.
Page
of 4